| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |